Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
869
-
Total 13F shares, excl. options
-
93.2M
-
Shares change
-
+2.98M
-
Total reported value, excl. options
-
$20.8B
-
Value change
-
+$661M
-
Put/Call ratio
-
2.07
-
Number of buys
-
440
-
Number of sells
-
-366
-
Price
-
$223.85
Significant Holders of RESMED INC - COM (RMD) as of Q1 2025
1,001 filings reported holding RMD - RESMED INC - COM as of Q1 2025.
RESMED INC - COM (RMD) has 869 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.2M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18.5M shares), BlackRock, Inc. (12.7M shares), STATE STREET CORP (6.55M shares), Bank of New York Mellon Corp (5.2M shares), MORGAN STANLEY (4.14M shares), GEODE CAPITAL MANAGEMENT, LLC (4.12M shares), Invesco Ltd. (2.29M shares), NORTHERN TRUST CORP (1.74M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (998K shares), and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (977K shares).
This table shows the top 869 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.